A NONSENSE MUTATION OF THE HUMAN LUTEINIZING-HORMONE RECEPTOR GENE IN LEYDIG-CELL HYPOPLASIA

被引:95
作者
LAUE, L
WU, SM
KUDO, M
HSUEH, AJW
CUTLER, GB
GRIFFIN, JE
WILSON, JD
BRAIN, C
BERRY, AC
GRANT, DB
CHAN, WY
机构
[1] GEORGETOWN UNIV,MED CTR,DEPT CELL BIOL & BIOCHEM,WASHINGTON,DC 20007
[2] STANFORD UNIV,MED CTR,DEPT OBSTET & GYNECOL,STANFORD,CA 94305
[3] NICHHD,DEV ENDOCRINOL BRANCH,BETHESDA,MD 20892
[4] UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,DALLAS,TX 75235
[5] GREAT ORMOND ST HOSP CHILDREN,LONDON,ENGLAND
[6] GUYS HOSP,LONDON SE1 9RT,ENGLAND
关键词
D O I
10.1093/hmg/4.8.1429
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Leydig cell hypoplasia (LCH) is a form of male pseudohermaphroditism in which Leydig cell differentiation and testosterone production are impaired, This report describes the first case of a nonsense mutation (A1635C) in exon 11 of the human luteinizing hormone receptor (hLHR) gene in two sisters with LCH. This mutation causes loss of function of the receptor by introducing a stop codon at residue 545 in transmembrane helix 5 of the hLHR. Surface expression of the truncated hLHR (hLHR-t545) in human embryonic kidney cells stably transfected with cDNA encoding hLHR-t545 was diminished compared to the wild-type hLHR and hCG-induced cAMP accumulation was impaired, These results establish that single base mutations in exon 11 of the hLHR gene can produce inactivation as well as activation of the hLMR. Furthermore, they demonstrate that functional domains between transmembrane helix 5 and the C-terminal cytoplasmic tail of the hLHR are required for normal cell surface expression of the receptor and signal transduction.
引用
收藏
页码:1429 / 1433
页数:5
相关论文
共 33 条
[1]   AN IMPROVED METHOD FOR THE SOLUBILIZATION OF STABLE GONADOTROPIN RECEPTORS [J].
ASCOLI, M .
ENDOCRINOLOGY, 1983, 113 (06) :2129-2134
[2]   GENETIC-EVIDENCE EQUATING SRY AND THE TESTIS-DETERMINING FACTOR [J].
BERTA, P ;
HAWKINS, JR ;
SINCLAIR, AH ;
TAYLOR, A ;
GRIFFITHS, BL ;
GOODFELLOW, PN ;
FELLOUS, M .
NATURE, 1990, 348 (6300) :448-450
[3]   LEYDIG-CELL AGENESIS - CAUSE OF MALE PSEUDOHERMAPHRODITISM [J].
BERTHEZENE, F ;
FOREST, MG ;
GRIMAUD, JA ;
CLAUSTRAT, B ;
MORNEX, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (18) :969-972
[4]   AMINO-TERMINAL LEUCINE-RICH REPEATS IN GONADOTROPIN RECEPTORS DETERMINE HORMONE SELECTIVITY [J].
BRAUN, T ;
SCHOFIELD, PR ;
SPRENGEL, R .
EMBO JOURNAL, 1991, 10 (07) :1885-1890
[5]  
BROWN DM, 1978, J CLIN ENDOCR METAB, V46, P1
[6]   CHARACTERIZATION OF THE CDNA-ENCODING HUMAN NUCLEOPHOSMIN AND STUDIES OF ITS ROLE IN NORMAL AND ABNORMAL GROWTH [J].
CHAN, WY ;
LIU, QR ;
BORJIGIN, J ;
BUSCH, H ;
RENNERT, OM ;
TEASE, LA ;
CHAN, PK .
BIOCHEMISTRY, 1989, 28 (03) :1033-1039
[7]   HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA [J].
CHEN, C ;
OKAYAMA, H .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) :2745-2752
[8]   VASOACTIVE INTESTINAL PEPTIDE - A NOVEL STIMULATOR OF STEROIDOGENESIS BY CULTURED RAT GRANULOSA-CELLS [J].
DAVOREN, JB ;
HSUEH, AJW .
BIOLOGY OF REPRODUCTION, 1985, 33 (01) :37-52
[9]   GERMLINE MUTATIONS IN THE THYROTROPIN RECEPTOR GENE CAUSE NON-AUTOIMMUNE AUTOSOMAL-DOMINANT HYPERTHYROIDISM [J].
DUPREZ, L ;
PARMA, J ;
VANSANDE, J ;
ALLGEIER, A ;
LECLERE, J ;
SCHVARTZ, C ;
DELISLE, MJ ;
DECOULX, M ;
ORGIAZZI, J ;
DUMONT, J ;
VASSART, G .
NATURE GENETICS, 1994, 7 (03) :396-401
[10]   ARG(60) TO LEU MUTATION OF THE HUMAN THROMBOXANE A(2) RECEPTOR IN A DOMINANTLY INHERITED BLEEDING DISORDER [J].
HIRATA, T ;
KAKIZUKA, A ;
USHIKUBI, F ;
FUSE, I ;
OKUMA, M ;
NARUMIYA, S .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (04) :1662-1667